Numerous studies have demonstrated the cardioprotective effects of endogenous and exogenous ghrelin in diverse cardiac conditions, including myocardial infarction (MI), ischemia/reperfusion injury (IRI), drug-induced cardiac injury, and heart failure (HF) [168,172,173,174]. This evidence concerns the gene GHRL and myocardial infarction.